Novo Nordisk, the maker of popular weight-loss drugs Ozempic and Wegovy, is partnering with OpenAI to deploy the technology across its operations as it looks to keep pace with rapid expansion in the obesity drug market. The Danish company announced in a statement on Tuesday that it would use AI to analyze complex datasets, identify promising drug candidates…
Politics
·
Novo Nordisk partners with OpenAI in weight loss drug race
CN
CitrixNews Staff
Originally reported by The Hill
Related Articles
Politics
Council investigates as postal vote problems leave ballots undelivered
Council investigates as postal vote problems leave ballots undelivered2 hours agoShareSaveAdd as preferred on GoogleElli...
CitrixNews Staff
·
2 hours ago
Politics
Mamdani skips Met Gala, calls attention to fashion workers
New York City Mayor Zohran Mamdani (D) may have skipped the Met Gala, but he still highlighted six fashion industry work...
CitrixNews Staff
·
4 hours ago
Politics
Shootings On the National Mall Are Rare
The National Mall and its surroundings are one of the least violent areas in Washington.
CitrixNews Staff
·
5 hours ago
Politics
Education Department launches Title XI investigation into all-women’s college
The Education Department on Monday opened a Title IX investigation into Smith College, a private all-women’s school, for...
CitrixNews Staff
·
5 hours ago